Literature DB >> 22785052

Newly diagnosed type 2 diabetes and risk of dementia: a population-based 7-year follow-up study in Taiwan.

Pei-Yu Cheng1, Hiu-Ngar Sy, Shey-Lin Wu, Wen-Fu Wang, Yen-Yu Chen.   

Abstract

BACKGROUND: Diabetes is associated with an increased risk of developing dementia. However, data on the patients with newly diagnosed type 2 diabetes are limited.
OBJECTIVE: To investigate the relationship between newly diagnosed type 2 diabetes and the risk of developing dementia, ischemic stroke and intracranial hemorrhage after disease diagnosis and the interrelationship between dementia and the stroke events.
METHOD: Data were collected from the National Health Insurance Research Database of Taiwan. The study cohort included 3717 patients newly diagnosed with type 2 diabetes and 37,170 age- and sex-matched comparison patients from the same period. All patients were tracked for 7 years following their index visit in 2000-2001. RESULT: After adjusting for potential confounders, dementia risk was approximately 63% higher (hazard ratio [HR], 1.63; 95% CI, 1.33-1.99) among newly diagnosed type 2 diabetic patients than among comparison subjects. Newly diagnosed type 2 diabetes also increased the risk of developing ischemic stroke but not intracranial hemorrhage. About 43.6% of diabetic patients who developed dementia also had ischemic stroke during the follow-up period, higher than the rate 29.6% in the comparison group.
CONCLUSION: This study shows that newly diagnosed type 2 diabetes is associated with a 63% higher future risk of dementia during the 7-year follow-up period. The high dementia and ischemic stroke overlap rate in the diabetic study group suggests vascular events play an important role in the pathogenesis of developing dementia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785052     DOI: 10.1016/j.jdiacomp.2012.06.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Authors:  Katherine J Bangen; Jayandra J Himali; Alexa S Beiser; Daniel A Nation; David J Libon; Caroline S Fox; Sudha Seshadri; Philip A Wolf; Ann C McKee; Rhoda Au; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

2.  Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: a retrospective national record linkage cohort study.

Authors:  Kate Smolina; Clare J Wotton; Michael J Goldacre
Journal:  Diabetologia       Date:  2015-02-12       Impact factor: 10.122

3.  Traumatic brain injury and age at onset of cognitive impairment in older adults.

Authors:  Wei Li; Shannon L Risacher; Thomas W McAllister; Andrew J Saykin
Journal:  J Neurol       Date:  2016-03-23       Impact factor: 4.849

4.  Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients.

Authors:  Chin-Hsiao Tseng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-30       Impact factor: 5.555

5.  Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study.

Authors:  Jie Zhen; Tong Lin; Xiaochen Huang; Huiqiang Zhang; Shengqi Dong; Yifan Wu; Linlin Song; Rong Xiao; Linhong Yuan
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745

6.  Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity.

Authors:  Keyi Wu; Huamin Liu; Jiazhen Zheng; Lianwu Zou; Shanyuan Gu; Rui Zhou; Zelin Yuan; Zhiwei Huang; Xianbo Wu
Journal:  Front Aging Neurosci       Date:  2022-01-06       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.